Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients

New England Journal of Medicine(2022)10.1056/nejmc2202861Source: DataRank Database

SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients is a research paper published in New England Journal of Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 110 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access110 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (8)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Ahmed Babiker ORCID,Max W. Adelman ORCID,Brent E. Allman ORCID,Autum Key ORCID,Jennifer Kleinhenz

Live enrichment

PubMed:35675197 PMC:PMC9202319

National Institute of Allergy and Infectious Diseases

Grant: K08AI139348 (AP)

NIAID NIH HHS

Grant: UM1 AI148576

National Institute of Allergy and Infectious Diseases

Grant: 5UM1AI148576-02 (NR and EMS)

CDC HHS

Grant: 75D30121C10084 under BAA ERR 20-15-2997 (AB, JW, K

NIAID NIH HHS

Grant: K08 AI139348

NIH HHS

Grant: contract No. 75N9301900065 (DW)

greenLicense: http://www.nejmgroup.org/legal/terms-of-use.htm

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9202319

publisherhttp://www.nejm.org/doi/pdf/10.1056/NEJMc2202861

Europe_PMChttps://europepmc.org/articles/PMC9202319

Europe_PMChttps://europepmc.org/articles/PMC9202319?pdf=render

MeSH Terms

HumansAntibodies, ViralNeutralization TestsEvolution, MolecularImmunocompromised HostCOVID-19SARS-CoV-2Antigenic Drift and Shift

Related Papers (10)

IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era

N/A

1.5DataRank · unranked

Molecular Biology and Evolution(2020)

co-cited

10.1093/molbev/msaa015

A pneumonia outbreak associated with a new coronavirus of probable bat origin

N/A

1.5DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2012-7

A new coronavirus associated with human respiratory disease in China

N/A

1.4DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2008-3

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

N/A

1.3DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2180-5

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

N/A

1.4DataRank · unranked

The Lancet(2020)

co-cited

10.1016/s0140-6736(20)30251-8

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

N/A

1.2DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2456-9

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

N/A

16.3DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2852-1

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

N/A

18.0DataRank · unranked

Nature Medicine(2021)

co-cited

10.1038/s41591-021-01285-x

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Journal of Clinical Investigation(2020)

co-cited

10.1172/jci142004

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

N/A

1.0DataRank · unranked

The Lancet(2021)

co-cited

10.1016/s0140-6736(21)00183-5